Scalable COVID-19 solutions to support your community
Accelerate vaccine distribution and address community testing needs with technology that solves complex scheduling and logistics challenges.
Learn MoreAlready a Solv partner?Log in
The complete COVID-19 solution for health departments, hospitals and retail clinics.
- Fast and easy deployment
- Handles high-volume appointment demand
- Improves the end-to-end workflow
- Increases clinic efficiency and throughput
- Intuitive scheduling accessible to all
- Automates reminders and data entry
Proven results with operators & communities
- 5.5m+
COVID tests scheduled
- 4000+
daily appointments processed per site
- less than 1
week from kick-off to go live
Built to support high volume
COVID testing and vaccine efforts
Flexible, multi-site appointment scheduling
Solv is able to support multiple visits per time interval for both COVID testing and vaccine appointments across all your sites, seamlessly blending both appointments with walk-in visits. Both first and second-dose vaccine appointments are supported. Leveraging Solv’s AI queuing technology, patients are seen at the right time and don’t wait longer than necessary.
Scalable to support thousands of visits daily
Unlike legacy healthcare technology and EMRs that were not built to handle high volume encounters, Solv is built to support thousands of COVID tests and vaccine appointments each day, per site. Our technology was used to schedule more than 5M COVID tests in 2020.
Efficient workflow for patients & providers
Solv’s solution simplifies COVID testing and vaccine logistics, allowing you to accelerate delivery in your community. It’s easy-to-use for everyone, scheduling a visit takes less than a minute, and requires no logins or long forms. And we even support reporting vaccine administration into IIS.
Vaccinating thousands of patients every day requires complex logistics and tight management of scheduling. Solv allows us to dynamically match our vaccine capacity with our schedule and communicates updates with patients to reduce appointment no-shows and deliver a great experience for patients.
Kevin Brooks, COO, Swedish Health Services
Free resources to help you deliver patient-centric care
Industry Updates
Solv Puts 100M+ Americans Within Reach Of A COVID-19 Vaccine In Preparation For Supply Surge
Solv is Working with VaccineFinder.org to Connect People to Local Vaccination Sites with Vaccine Availability Solv for Vaccines Solution Equips Health Departments to Ramp Up Multiple New Vaccination Sites and Start Booking High-Volume, High-Speed Appointments in Less Than a Week Solv Ready w
Industry Updates
Introducing Solv for Vaccines: Give your community quicker access to COVID-19 vaccinations
2021 has kicked off with new hope thanks to the COVID-19 vaccine. Two multi-dose vaccine options are currently available with single dose formulations likely to be approved soon. The CDC has provided vaccine phase recommendations, the initial doses have been distributed to states, and administration
Case Studies
Webinar: A case study of the City of Seattle's COVID-19 testing program
The City of Seattle was ground zero fo the COVID-19 pandemic in the US and they've been recognized a national leader in their response and testing strategies ever since. Solv has been both fortunate enough to work alongside them as they ramped up their testing efforts, and to have them join us in sh
Clinic Operations
How to Successfully Support Vaccine Administration with Solv
With COVID-19 vaccine production surging, more providers and clinics are stepping up to support vaccine administration within their communities. To deliver vaccines efficiently and effectively, quickly equipping teams with better tools for patient scheduling, screening, and communication is key for
Case Studies
Michigan National Guard Rapidly Deploys Solv to Vaccinate Troops
Fast, scalable effort to inoculate the workforce tasked with statewide vaccine delivery. 9 vaccination sites at Michigan National Guard installations launched in under a week. In December, upon Gov. Gretchen Whitmer’s request, the State of Michigan received federal authorization in December to use